Major drug company shares declined Friday after President Donald Trump announced 100% tariffs on imported branded medications, though analysts believe most large pharmaceutical firms will escape serious financial damage from these trade policies. Indian drug manufacturers experienced stock price decreases even as industry specialists indicated the tariffs would barely affect their business operations. Share values for Sun Pharmaceutical dropped 2.5% while Divi’s Laboratories fell 3.5% on Friday. The sector benchmark Nifty Pharma Index dropped over 2%.